Skip to main content
OpenTrials
Completed

NCT Number: NCT01602640

Comparison of Morphine and Fentanyl/Midazolam in Intensive Care Unit

Hypothesis: Morphine infusion decreases time to mechanical ventilation weaning and extubation, as compared to the combination of fentanyl and midazolam in critically-ill patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Failure Respiration Disorders Respiratory Insufficiency Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinica de los Andes IPS

Tunja, Departamento de Boyacá, 8, Colombia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults admitted to ICU requiring mechanical ventilation Informed consent

Exclusion criteria

  • Less than 18 years old
  • Consent denial

Treatment and study plan

Morphine Infusion

Drug

Conventional dose

Fentanyl and Midazolam infusion

Drug

Conventional dose

Primary outcomes

  1. Time from sedation discontinuation to first T-Tube time from sedation

    Time frame: 12-120 hours

Secondary outcomes

  1. Time from sedation discontinuation to extubation time from sedation

    Time frame: 12-180 hours

Sponsors and collaborators

Lead sponsor

Clínica de Los Andes IPS

Other

Registry information

Official study title

Sedation and Analgesia in Intensive Care: Comparison of Morphine and Fentanyl/Midazolam

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
May 21, 2012
Registry last updated
May 21, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.